Liver fibrosis assessment in long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
- Authors: Panevkina S.V1, Abdurakhmanov D.T2, Ibragimov E.K2, Rozina T.P1,2, Nikulkina E.N2, Tanaschuk E.L2, Odintsov A.V2, Moiseev S.V1,2
-
Affiliations:
- M.V. Lomonosov Moscow State University
- I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
- Issue: Vol 7, No 6 (2021)
- Pages: 24-31
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288399
- DOI: https://doi.org/10.18565/therapy.2021.6.24-31
- ID: 288399
Cite item
Abstract
Full Text
About the authors
S. V Panevkina
M.V. Lomonosov Moscow State University
Email: panevkina.sophia0gmailcom
119192, Moscow, 27/1 Lomonosovsky Avenue. Tel.: +7 (977) 855-61-33
D. T Abdurakhmanov
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: abdjamal0mail.ru
119992, Moscow, 11/5 Rossolimo Str. Tel.: +7 (926) 280-34-31
E. K Ibragimov
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: elhan86840mail.ru
119992, Moscow, 11/5 Rossolimo Str
T. P Rozina
M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: alrozin0yandex.ru
119992, Moscow, 11/5 Rossolimo Str
E. N Nikulkina
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: nikulkene0mail.ru
119992, Moscow, 11/5 Rossolimo Str
E. L Tanaschuk
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: elena_tanaschuk0mail.ru
119992, Moscow, 11/5 Rossolimo Str
A. V Odintsov
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: alexeyodintsov0mail.ru
119992, Moscow, 11/5 Rossolimo Str
S. V Moiseev
M.V. Lomonosov Moscow State University; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: avt4200340gmail.com
119992, Moscow, 11/5 Rossolimo Str
References
- Kim J.H., Jung S.W., Byun S.S. et al. Efficacy and safety of tenofovir in nucleos(t)ide-nai've patients with genotype C chronic hepatitis B in real-life practice. Int J Clin Pharm. 2015; 37(6): 1228-34. doi: 10.1007/s11096-015-0193-1.
- Osborn M.K. Safety and efficacy of telbivudine for the treatment of chronic hepatitis B. Ther Clin Risk Manag. 2009; 5: 789-98. doi: 10.2147/tcrm.s5318.
- European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2): 370-98. doi: 10.1016/j.jhep.2017.03.021.
- Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008; 48(5): 835-47. doi: 10.1016/j.jhep.2008.02.008.
- Shaheen A.A., Wan A.F., Myers R.P. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007; 102(11): 2589-600. doi: 10.1111/j.1572-0241.2007.01466.x.
- Ying H.Y., Lu L.G., Jing D.D. et al. Accuracy of transient elastography in the assessment of chronic hepatitis C-related liver cirrhosis. Clin Invest Med. 2016; 39(5): E150-E160. doi: 10.25011/cim.v39i5.27147.
- Masuzaki R., Tateishi R., Yoshida H. et al. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol. 2008; 22(9): 753-57. doi: 10.1155/2008/306726.
- Degos F., Perez P., Roche B. et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010; 53(6): 1013-21. doi: 10.1016/j.jhep.2010.05.035.
- Kettaneh A., Marcellin P., Douvin C. et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol. 2007; 46(4): 628-34. doi: 10.1016/j. jhep.2006.11.010.
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009; 50(2): 227-42. doi: 10.1016/j.jhep.2008.10.001.
- Rockey D.C., Bell P.D., Hill J.A. Fibrosis - a common pathway to organ injury and failure. N Engl J Med. 2015; 372(12): 1138-49. doi: 10.1056/NEJMra1300575.
- Rockey D.C. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol. 2013; 11(3): 224-31.e1-5. doi: 10.1016/j.cgh.2013.01.005.
- Kim M.N., Kim S.U., Kim B.K. et al. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir. Liver Int. 2014; 34(8): 1216-23. doi: 10.1111/liv.12377.
- Zeng J., Cai S., Liu J. et al. Dynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis B. J Ultrasound Med. 2017; 36(2): 261-68. doi: 10.7863/ultra.15.12054.
- Facciorusso A., Garcia Perdomo H.A., Muscatiello N. et al. Systematic review with meta-analysis: Change in liver stiffness during antiviral therapy in patients with hepatitis B. Dig Liver Dis. 2018; 50(8): 787-94. doi: 10.1016/j.dld.2018.05.005.
- Marcellin P., Gane E., Buti M. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study. Lancet. 2013; 381(9865): 468-75. doi: 10.1016/S0140-6736(12)61425-1.
- Kim J.K., Ma D.W., Lee K.S. et al. Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents. J Korean Med Sci. 2014; 29(4): 570-75. doi: 10.3346/jkms.2014.29.4.570.
- Andersen E.S., Weiland O., Leutscher P. et al. Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scand J Gastroenterol. 2011; 46(6): 760-66. doi: 10.3109/00365521.2011.565068.
- Kuo Y.H., Lu S.N., Chen C.H. et al. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. PLoS One. 2014; 9(3): e93160. doi: 10.1371/journal.pone.0093160.
- Christiansen K.M., Mossner B.K., Hansen J.F. et al. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study. PLoS One. 2014; 9(11): e111912. doi: 10.1371/journal.pone.0111912.
- Jang W., Yu S.I., Sinn D.H. et al. Longitudinal change of liver stiffness by transient elastography in chronic hepatitis B patients treated with nucleos(t)ide analogue. Clin Res Hepatol Gastroenterol. 2014; 38(2): 195-200. doi: 10.1016/j.clinre.2013.10.003.
- Ogawa E., Furusyo N., Murata M. et al. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res. 2011; 41(12): 1178-88. doi: 10.1111/j.1872-034X.2011.00869.x.
- Chang T.T., Liaw Y.F., Wu S.S. et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010; 52(3): 886-93. doi: 10.1002/hep.23785.
- Buti M., Fung S., Gane E. et al. Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatol Int. 2015; 9(2): 243-50. doi: 10.1007/s12072-015-9614-4.
- Chon Y.E., Park J.Y., Myoung S.M. et al. Improvement of liver fibrosis after long-term antiviral therapy assessed by Fibroscan in chronic hepatitis B patients with advanced fibrosis. Am J Gastroenterol. 2017; 112(6): 882-91. doi: 10.1038/ajg.2017.93.
- Rinaldi L., Ascione A., Messina V. et al. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. Infection. 2018; 46(2): 231-38. doi: 10.1007/s15010-017-1113-1.
- Fung J., Lai C.L., But D. et al. Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int. 2010; 4(4): 716-22. doi: 10.1007/s12072-010-9189-z.
- Fung J., Lai C.L., Cheng C. et al. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol. 2011; 106(3): 492-96. doi: 10.1038/ajg.2010.463.